|
|
|
|
|
|
Sponsors and Collaborators: |
Seoul National University Hospital Hallym University Medical Center Gachon University Gil Medical Center |
Information provided by: | Seoul National University Hospital |
ClinicalTrials.gov Identifier: | NCT00328952 |
The purpose of this study is to evaluate the changes in various aspects of auditory verbal hallucinations during 24-week antipsychotic treatment in naturalistic condition.
Condition |
Schizophrenia Hallucinations |
MedlinePlus related topics: | Schizophrenia |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Naturalistic Multicenter Study of Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Schizophrenia |
Enrollment: | 40 |
Study Start Date: | August 2004 |
Estimated Study Completion Date: | August 2008 |
Auditory verbal hallucinations (AVH), meaning the experience of hearing voices, occur in 60-75% of patients with schizophrenia. Patients experiencing persistent AVH tend to be interrupted in their daily routines and have trouble keeping regular jobs due to the intrusiveness or abusive contents of voices. In addition, auditory hallucinations are reported to remain even after disappearance of other psychotic symptoms in many patients with schizophrenia spectrum disorders after treatment with typical antipsychotics.
The study involves detailed phenomenological assessments of AVH and other psychotic symptoms, as well as side effects of atypical antipsychotics.
Ages Eligible for Study: | 15 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Korea, Republic of | |||||
Seoul National University Hospital | |||||
Seoul, Korea, Republic of, 110-744 |
Seoul National University Hospital |
Hallym University Medical Center |
Gachon University Gil Medical Center |
Study Director: | Jong-Hoon Kim, MD, PhD | Gachon University Gil Medical Center |
Study Director: | Jung Seo Yi, MD, PhD | Hallym University Medical Center |
Click here for detailed information about the experience of hearing voices. 
  |
Click here for the information about approaches to hallucination control in schizophrenia. 
  |
Study ID Numbers: | KYS-2006-05018 |
First Received: | May 22, 2006 |
Last Updated: | April 7, 2008 |
ClinicalTrials.gov Identifier: | NCT00328952 |
Health Authority: | South Korea: Korea Food and Drug Administration (KFDA) |
|
|
|
|